Communiqués Fresenius Cinnober Boat

Actions

0OO9

DE0005785604

Installations et services en soins de santé

Temps Différé Cinnober Boat			Varia. 5j.	Varia. 1 janv.
- ^EUR	-.--%		-.--%	-

18/08	Frasers détient désormais près de la moitié du capital d'Hugo Boss	AW
18/08	Le distributeur britannique Frasers porte sa participation dans Hugo Boss à près de 48 %	RE

Communiqués

10/08	Fitch Ratings upgrades outlook for Fresenius SE from stable to positive	EQ
06/08	Fresenius transitions to registered shares – automatic conversion for shareholders	EQ
04/08	#FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised	EQ
04/08	Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance	EQ
03/08	Fresenius : Announces FDA Approval of Rituximab Biosimilar for the U.S. Market	PU
31/07	Fresenius : Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate	PU
23/07	Fresenius establishes venture fund of more than €200 million to drive healthcare innovation	EQ
15/07	Fresenius : Q2 2026 Aide Memoire available	PU
13/07	Fresenius : GKV Stabilization Act approved	PU
01/07	Fresenius : successfully issues €1 billion in bonds	PU
01/06	Fresenius SE & Co. KGaA: Michael Sen, buy	EQ
22/05	2026 Annual General Meeting of Fresenius: Shareholders approve all agenda items	EQ
22/05	2026 Annual General Meeting: Fresenius delivers strong performance in 2025 and proposes 5% increase in dividends	EQ
08/05	Fresenius SE & Co. KGaA: Michael Sen, buy	EQ
06/05	Fresenius invests in Avelios Medical and further expands its strategic partnership with SAP	EQ
06/05	Fresenius : Conference Call Q1/2026 (May 5, 2026)	PU
06/05	#FutureFresenius: REJUVENATE in action – Excellent start to the year - demonstrating continued strength and resilient performance; Guidance reconfirmed	EQ
17/04	Fresenius : Q1 2026 Aide Memoire available	PU
13/04	Fresenius : FY/25 Fresenius Factsheet	PU
09/04	Fresenius : General Credit Presentation (April 8, 2026)	PU
09/04	Fresenius : Investor Presentation (March 1, 2026)	PU
08/04	AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 22.05.2026 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution	EQ
08/04	#FutureFresenius is paying off: S&P Global Ratings revises outlook for Fresenius SE from stable to positive	EQ
01/04	Fresenius SE & Co. KGaA: Michael Sen, buy	EQ
01/04	Fresenius SE & Co. KGaA: Pierluigi Antonelli, buy	EQ